Lucy Coassin

Lucy Coassin

Private Equity Investor en Northpond Ventures LLC .

Consumer Services
Commercial Services
Health Technology

Perfil

Lucy Coassin is a Principal at Northpond Ventures.
She is a board director at Hawthorne Effect, Story Health, and Vital Biosciences, and a board observer at Vizgen.
Previously, Lucy was Head of Pharma at Current Health (a Northpond portfolio company, acquired by Best Buy).
She has 15 years of experience commercializing technology from product launch to widespread adoption.
Lucy has held business development and commercial roles at digital health and life science tool companies including Science 37 (NASDAQ: SNCE), Farcast Biosciences, Genentech, and Life Technologies (Acquired by ThermoFisher, NYSE: TMO).
Lucy received her MBA from the Stanford Graduate School of Business and a B.S.
with distinction in Chemistry from Duke University.

Cargos activos de Lucy Coassin

EmpresasCargoInicio
Private Equity Investor 01/03/2023
Private Equity Investor -
Private Equity Investor -
Private Equity Investor -
Todos los cargos activos de Lucy Coassin

Formación de Lucy Coassin.

Duke University Undergraduate Degree
Stanford University Masters Business Admin

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Lucy Coassin.

Relaciones

99

Relaciones de 1er grado

6

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas4

Commercial Services

Health Technology

Finance

Technology Services

Ver las conexiones de la empresa